Exhibit 32.2

              SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In   connection   with   the   quarterly   report   (the   "Report")   of  China
Biopharmaceuticals Holdings, Inc. (the "Company") on Form 10-QSB for the quarter
ended September 30, 2005 as filed with the Securities and Exchange Commission on
the date  hereof,  I, HUANG  Chentai,  Chief  Financial  Officer of the Company,
certify,  pursuant  to 18  U.S.C.  1350,  as  adopted  pursuant  to  906  of the
Sarbanes-Oxley Act of 2002, that to my knowledge:

1.   The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.



Date: November 14, 2005                               By: /s/ HUANG Chentai
                                                         -----------------------
                                                         HUANG Chentai
                                                         Chief Financial Officer